Author:
A. Bird Brian,Y. Cheung Albert,D. Sheppard John
Abstract
The primary focus of this book chapter is to investigate and discuss the impact of corneal disease and how various types of corneal pathology can affect the surgeons preop, intraop and post op management when considering cataract surgery for a patient. Cataract surgery is known to exacerbate ocular surface diseases like dry eye, HSV, inflammatory conditions like ocular cicatricial pemphigoid, SJS, peripheral ulcerative keratitis, Moorens ulcer and endothelial disease like Fuch’s dystrophy secondary to intraoperative endothelial cell loss. Preoperative treatment including optimization of the corneal surface, antiviral prophylaxis in HSV keratitis, quiescence of inflammation and preoperative diagnostic evaluation of endothelial cell counts may all play a role in postoperative outcomes. Corneal disease may also impact intraoperative considerations in cataract extraction to include the use of scleral tunnels or even Extracapsular Cataract extraction techniques, for example, in patients with Mooren’s ulcer to decrease corneal melt. More commonly corneal disease consequently provides a poor view for the surgeon and unfavorable post op visual acuity for the patient. Consideration of staged keratoplasty and cataract surgery vs. combined “triple procedure” have both been shown as reasonable treatment options. Postoperative considerations include management of endothelial cell loss during surgery and minimizing postoperative eye drops and medicomentosa.
Reference98 articles.
1. GBD 2019 Blindness and Vision Impairment Collaborators; Vision Loss Expert Group of the Global Burden of Disease Study. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The right to sight: An analysis for the global burden of disease study. The Lancet Global Health. 2021;(2):e144-e160. DOI: 10.1016/S2214-109X(20)30489-7 Epub 2020 Dec 1. Erratum in: Lancet Glob Health. 2021;9(4):e408
2. Mason L, Jafri S, Dortonne I, Sheppard JD Jr. Emerging therapies for dry eye disease. Expert Opinion on Emerging Drugs. 2021;(4):401-413. DOI: 10.1080/14728214.2021.2011858 Epub 2021 Dec 7
3. Rouen PA, White ML. Dry eye disease. Home Healthcare Now. 2018;(2):74-83
4. Basic and clinical science course. Orbit, eyelids, and lacrimal system. American Academy of Ophthalmology. 2012;:243-244
5. Epitropoulos AT, Matossian C, Berdy GJ, Malhotra RP, Potvin R. Effect of tear osmolarity on repeatability of keratometry for cataract surgery planning. Journal of Cataract and Refractive Surgery. 2015;:1672-1677